Xponance’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.68M | Buy |
21,379
+281
| +1% | +$35.3K | 0.02% | 470 |
|
|
2025
Q1 | $2.89M | Buy |
21,098
+363
| +2% | +$49.7K | 0.03% | 434 |
|
|
2024
Q4 | $3.17M | Sell |
20,735
-290
| -1% | -$44.3K | 0.03% | 405 |
|
|
2024
Q3 | $4.08M | Sell |
21,025
-56
| -0.3% | -$10.9K | 0.04% | 353 |
|
|
2024
Q2 | $4.89M | Buy |
21,081
+45
| +0.2% | +$10.4K | 0.05% | 288 |
|
|
2024
Q1 | $4.54M | Buy |
21,036
+989
| +5% | +$213K | 0.05% | 321 |
|
|
2023
Q4 | $5.19M | Sell |
20,047
-1,246
| -6% | -$322K | 0.06% | 253 |
|
|
2023
Q3 | $5.47M | Buy |
21,293
+1,446
| +7% | +$372K | 0.07% | 224 |
|
|
2023
Q2 | $5.65M | Buy |
19,847
+67
| +0.3% | +$19.1K | 0.08% | 227 |
|
|
2023
Q1 | $5.5M | Buy |
19,780
+497
| +3% | +$138K | 0.08% | 234 |
|
|
2022
Q4 | $5.34M | Buy |
19,283
+4,183
| +28% | +$1.16M | 0.09% | 226 |
|
|
2022
Q3 | $4.03M | Buy |
15,100
+2,570
| +21% | +$686K | 0.08% | 229 |
|
|
2022
Q2 | $2.56M | Buy |
12,530
+2,739
| +28% | +$559K | 0.05% | 318 |
|
|
2022
Q1 | $2.06M | Buy |
9,791
+364
| +4% | +$76.7K | 0.03% | 366 |
|
|
2021
Q4 | $2.26M | Buy |
9,427
+1,894
| +25% | +$454K | 0.04% | 349 |
|
|
2021
Q3 | $2.13M | Sell |
7,533
-810
| -10% | -$229K | 0.04% | 332 |
|
|
2021
Q2 | $2.89M | Sell |
8,343
-2,953
| -26% | -$1.02M | 0.05% | 279 |
|
|
2021
Q1 | $3.16M | Sell |
11,296
-229
| -2% | -$64.1K | 0.07% | 232 |
|
|
2020
Q4 | $2.82M | Sell |
11,525
-9,545
| -45% | -$2.34M | 0.06% | 253 |
|
|
2020
Q3 | $5.98M | Sell |
21,070
-2,539
| -11% | -$720K | 0.15% | 124 |
|
|
2020
Q2 | $6.32M | Buy |
+23,609
| New | +$6.32M | 0.16% | 127 |
|